ArrowMark Colorado Holdings’s Transmedics TMDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2M Sell
30,151
-140,917
-82% -$11.9M 0.08% 225
2026
Q1
$17M Sell
171,068
-15,911
-9% -$2.08M 0.45% 67
2025
Q4
$22.7M Sell
186,979
-126,146
-40% -$15.8M 0.5% 62
2025
Q3
$35.1M Buy
313,125
+109,830
+54% +$12.9M 0.65% 47
2025
Q2
$27.2M Buy
203,295
+167,670
+471% +$18.4M 0.49% 67
2025
Q1
$2.4M Sell
35,625
-241,795
-87% -$16.6M 0.04% 219
2024
Q4
$17.3M Sell
277,420
-695,983
-71% -$64.8M 0.23% 100
2024
Q3
$153M Sell
973,403
-165,389
-15% -$25.5M 1.96% 9
2024
Q2
$172M Buy
1,138,792
+58,866
+5% +$7.06M 2.05% 11
2024
Q1
$79.8M Buy
1,079,926
+59,088
+6% +$4.87M 0.9% 34
2023
Q4
$80.6M Buy
1,020,838
+277,798
+37% +$16.8M 0.89% 37
2023
Q3
$40.7M Buy
743,040
+622,892
+518% +$44.8M 0.5% 61
2023
Q2
$10.1M Buy
120,148
+7,578
+7% +$580K 0.11% 146
2023
Q1
$8.52M Sell
112,570
-34,871
-24% -$2.41M 0.1% 155
2022
Q4
$9.1M Sell
147,441
-52,945
-26% -$2.81M 0.11% 156
2022
Q3
$8.36M Buy
+200,386
New +$8.71M 0.1% 171
2019
Q3
Sell
-198,211
Closed -$5.75M 342
2019
Q2
$5.75M Buy
+198,211
New +$5.41M 0.06% 198

Other funds holding TMDX

ArrowMark Colorado Holdings's TMDX Position: Q2 2026 in Review

ArrowMark Colorado Holdings reduced its Transmedics (TMDX) stake by 82% in Q2 2026, selling an estimated $11.9M and leaving 30,151 shares worth $2M. The position accounts for 0.08% of the portfolio, ranked #225.

ArrowMark Colorado Holdings first reported a position in TMDX in Q2 2019 and has held it in 17 quarters since. The position peaked at $172M in Q2 2024. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • ArrowMark Colorado Holdings held 30,151 shares of Transmedics worth $2M as of Q2 2026.
  • ArrowMark Colorado Holdings sold 140,917 Transmedics shares in Q2 2026, an estimated $11.9M.
  • Transmedics made up 0.08% of ArrowMark Colorado Holdings's portfolio in Q2 2026, its #225 holding.
  • ArrowMark Colorado Holdings first reported a position in Transmedics in Q2 2019 and has held it in 17 quarters since.
  • ArrowMark Colorado Holdings's Transmedics position peaked at $172M in Q2 2024.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on ArrowMark Colorado Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.